🔎 Trials Near Me

Akèy › Maladi Alzheimer › Illinois › Chicago

Etid klinik pou Maladi Alzheimer nan Chicago, IL

11 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
  • RE:Cognition (Chicago), Chicago
  • Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville, Chicago
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Andersonville, Chicago
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Ap rekriteFaz 3
  • Re:Cognition Health - Chicago, Chicago
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216

Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music

Ap rekrite
  • Northwestern University Feinberg School of Medicine, Chicago
Laj 55 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07775625

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • John H. Stroger, Jr. Hospital of Cook County, Chicago
  • University of Chicago - Medical Center, Chicago
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Insigth Hospital and Medical Center Chicago, Chicago
Laj 40 a 90 · Tout sèks · Mizajou Jul 14, 2026 · NCT07701161

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Ap rekriteFaz 3
  • Great Lakes Clinical Trials - Andersonville, Chicago
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

Communication Bridge 3 Study

Ap rekriteFaz 2
  • University of Chicago - American School Building, Chicago
Laj 18 a 100 · Tout sèks · Mizajou Jun 1, 2026 · NCT06191198

Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Jun 5, 2025 · NCT07005895

Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

Ap rekriteEtid obsèvasyon
  • Full List of Active Sites, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Dec 14, 2023 · NCT06170268

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.